Show results for
Refine by
Preclinical Data From Cytotil15 Program Equipment Supplied In Israel
12 equipment items found
by:OSSIO Inc based inWoburn, MASSACHUSETTS (USA)
OSSIOfiber® Cannulated and Solid-Core Fixation Nails allow surgeons to offer patients a strong and biointegrative solution for a wide range of surgical techniques. Comprised of OSSIOfiber® Intelligent Bone Regeneration Technology, Fully integrates into native anatomy without adverse inflammation,, as proven in pre-clinical studies, Rivals performance of metal headless cannulated ...
Manufactured by:Algatech based inD.N Hevel Eilot, ISRAEL
The human eye is a highly complex organ comprised of multiple tissue types, layers, and components that must work perfectly in sync and be constantly maintained. The retina of the eye is especially vulnerable to oxidative damage because it is one of the highest oxygen-consuming tissues of the body and experiences some of the greatest production of ROS. Antioxidants, especially carotenoids, are a ...
Manufactured by:BiomX based inNess Ziona, ISRAEL
We are developing BX005, a topical phage cocktail that targets Staphylococcus aureus (S. aureus), a bacteria associated with the manifestation of the disease. This program leverages know-how and capabilities acquired under our previous programs with regard to topical formulation and clinical testing. In preclinical in vitro studies, BX005 was shown to be active against over 90% of strains of S. ...
Manufactured by:BiomX based inNess Ziona, ISRAEL
We are developing BX004, a phage therapy for CF patients with chronic Pseudomonas aeruginosa (P. aeruginosa) respiratory infections, a main contributor to morbidity and mortality in this disease. Phase 1b/2a clinical study in CF patients is composed of two parts. Results from Part 1 aimed to evaluate the safety, pharmacokinetics, and microbiologic/clinical activity are expected in Q3 of 2022. ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
PLX-Immune are cells that have been induced with tumor necrosis factor alpha (TNF-a) and interferon-gamma (IFN-g), to transiently alter their secretion profile. The product has been evaluated in pre-clinical studies and a peer-reviewed article in the journal Scientific Reports, from Nature, was published which examined the effect of the cells in over 50 lines of human cancerous cells. The results ...
by:OSSIO Inc based inWoburn, MASSACHUSETTS (USA)
Bio-Integrative OSSIOfiber® Hammertoe Fixation System. Innovation and Convenience Delivered In One Package. The combination of the implant plus disposable instrumentation provides easy insertion and secure fixation for proximal interphalangeal (PIP) fusion procedures while utilizing existing surgical ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
PLX-R18 cells release a combination of therapeutic proteins in response to a damaged or poorly functioning hematopoietic system; this system creates the blood cells that protect us from infection, uncontrolled bleeding and anemia. PLX-R18 is currently in a Phase I clinical trial to treat incomplete hematopoietic recovery following Hematopoietic Cell Transplantation (HCT) and in development to ...
by:OSSIO Inc based inWoburn, MASSACHUSETTS (USA)
Bio-Integrative OSSIOfiber® Compression Screw and Sterile, Disposable Instrumentation. Superior Fixation meets Better Bone Healing. The Patient Experience is Yours to Transform. Our Compression Screws deliver superior performance to conventional metal screws1,2 and gradually integrate fully into bone, for a true return to full strength and a total healing that other implants simply ...
by:Kadimastem Ltd. based inNes-Ziona, ISRAEL
Clinical grade human astrocytes (the nervous system supporting cells) for the treatment of ALS and other neurodegenerative diseases. Received approval by the Israeli Ministry of Health to commence our phase I/IIa clinical trial in ALS patients. 6 month follow up results for Cohort B have been ...
Manufactured by:Lineage Cell Therapeutics, Inc. based inCarlsbad, CALIFORNIA (USA)
OPC1 is an oligodendrocyte progenitor cell therapy that is currently in a Phase 1/2a multicenter clinical trial for acute spinal cord injuries (SCI). Oligodendrocyte progenitor cells (OPCs) are naturally-occurring precursors to the cells which provide electrical insulation for nerve axons in the form of a myelin sheath. SCI occurs when the spinal cord is subjected to a severe crush or contusion ...
by:Kadimastem Ltd. based inNes-Ziona, ISRAEL
We Have Reached Successful Pre-clinical results of our cell Therapy Treatment for Insulin-Dependent Diabetes. Diabetes mellitus is a chronic disorder characterized by high blood glucose levels and glucose intolerance, due to insulin deficiency, impaired effectiveness of insulin action, or both. Diabetes is classified on the basis of cause and clinical presentation into two major types: type 1 ...
Manufactured by:RedHill Biopharma Ltd. based inTel-Aviv, ISRAEL
Opaganib (ABC294640) is a first-in-class, proprietary sphingosine kinase-2 (SK2) selective inhibitor, administered orally, with anticancer, anti-inflammatory and anti-viral ...